Amneal to Report Second Quarter 2024 Results on August 9, 2024

Rhea-AI Summary

Amneal Pharmaceuticals (NASDAQ: AMRX) will release its second quarter 2024 financial results on August 9, 2024, before market open.

The company will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss the results.

Details for accessing the call and webcast are available on the company's Investor Relations website.

Participants need to register for the conference call to receive dial-in details and a unique PIN.

A replay of the call will be accessible for seven days following the event.

Positive

• Amneal Pharmaceuticals is actively engaging with the investment community by hosting a live webcast and conference call.
• Accessibility of financial results and webcast through the Investor Relations section of the company's website.

Negative

• None.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its second quarter 2024 financial results on Friday, August 9, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time.

The financial results and live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com.

Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call.

To access the call through a conference line, dial 1 (833) 470-1428 (in the U.S.) or for a list of toll-free international numbers, visit this link. The access code for the call is 462066.

A replay of the conference call will be posted shortly after the call and will be available for seven days.

About Amneal

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global pharmaceutical company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 pharmaceutical products, primarily within the United States. In its Generics segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240711590201/en/

Investor Contact

Anthony DiMeo

VP, Investor Relations & Media

anthony.dimeo@amneal.com

Source: Amneal Pharmaceuticals, Inc.

FAQ

When will Amneal Pharmaceuticals release its Q2 2024 financial results?

Amneal Pharmaceuticals will release its Q2 2024 financial results on August 9, 2024, before market open.

What time is Amneal Pharmaceuticals' Q2 2024 earnings call?

Amneal Pharmaceuticals' Q2 2024 earnings call is scheduled for 8:30 a.m. Eastern Time on August 9, 2024.

How can I access Amneal Pharmaceuticals' Q2 2024 earnings call?

You can access Amneal Pharmaceuticals' Q2 2024 earnings call by registering on the Investor Relations section of their website to receive dial-in details and a unique PIN.

Will there be a replay available for Amneal Pharmaceuticals' Q2 2024 earnings call?

Yes, a replay of Amneal Pharmaceuticals' Q2 2024 earnings call will be available for seven days after the event.